Infosys is guiding for a modest, low-single digit percentage increase in its top line for fiscal 2025, and it is fair to say that the company's guidance is unimpressive. On the flip side, INFY's ...
Narrow-moat Infosys INFY reported first-quarter earnings below our expectations. Management offered a grimmer outlook for 2024 revenue growth, citing clients’ revision of discretionary spending and ...
BENGALURU: Infosys forecast one of its weakest revenue guidance ranges, between 0% and 3% for 2025-26, mainly due to macroeconomic uncertainties and tariff-related concerns. According to the company, ...
Infosys demand remains steady despite global uncertainty, with a $4.8 billion deal pipeline and rising AI revenues giving visibility to future growth. Brokerage JM Financial says improving ...
Infosys shares rose in trade after the IT major offered a resilient FY26 growth outlook, helping offset concerns around its ...
Gov. Roy Cooper, left, and Infosys president Ravi Kumar announced in 2017 that the tech expected to create 2,000 jobs in the Triangle. It acknowledged Tuesday that it would not meet that goal. Chris ...
BENGALURU: Infosys filed a counterclaim against Cognizant in a US court, alleging that its rival Cognizant and its CEO, Ravi Kumar, engaged in anticompetitive practices to stifle competition and ...
Global IT consultancy Infosys is joining forces with energy giant Shell on a project that is geared towards accelerating the adoption of immersion cooling technologies in datacentres. The ...
Aurobindo Pharma announced that its subsidiary, CuraTeQ Biologics, has entered into a marketing and distribution agreement with STADA Arzneimittel AG. STADA will commercialize two EMA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results